Injection Pen Market Size Estimated To Reach At USD 67.9 Billion By 2025 | Owen Mumford Ltd.; GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.; AstraZeneca; Novo Nordisk; Sanofi; and Sandoz Inc

Injection Pen Market Size Estimated To Reach At USD 67.9 Billion By 2025 | Owen Mumford Ltd.; GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.; AstraZeneca; Novo Nordisk; Sanofi; and Sandoz Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, Increasing incidence of diseases such as diabetes and arthritis, increasing geographical reach of market players, and high demand for safer and advanced drug delivery devices expected to drive the market during the forecast period.

The global injection pen market is expected to reach USD 67.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.4% CAGR during the forecast period. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.

Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.

Japan injection pens market size, by product, 2014 - 2025 (USD Million)

Request a sample Copy of the Injection Pen Market Research Report @

Key Takeaways Of The Report :

  • Rising incidence of diseases such as diabetes and arthritis is primarily boosting market growth

  • Increase in government healthcare expenditure and availability of favorable healthcare insurance policies in developed as well as developing countries is driving the market

  • By product, reusable injectable pens are the largest and fastest growing segment owing to the advantages associated with them such as cost effectiveness and patient convenience. Commercially available reusable injectable pens mainly include Novopen, Luxura, Berlipen, AllStar, NovoRapid, basalgar, Bydureon, Epipen and Genotropin

  • By dosage, variable dosage is the fastest growing segment. Some of the customizable variable pens are UnoPen, ServoPen and Ypsopen by Ypsomed, Madie by SHL Group, and Evo pen by Copernicus

  • North America dominates the market, followed by Europe. Technological advancements and increase in incidence of osteoporosis, arthritis, and anaphylaxis are factors that can be attributable to its largest market share

  • Asia Pacific is expected to be the fastest growing region over the forecast period. Better accessibility to healthcare, coupled with constantly increasing healthcare expenditure in the region, is fueling market growth

  • China is one of the most lucrative markets with tremendous growth opportunities for global as well as local players. This is owing to favorable factors such as availability of labor and raw materials at significantly lower prices as compared to other regions

  • Key players in the market include Owen Mumford Ltd.; GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.; AstraZeneca; Novo Nordisk; Sanofi; and Sandoz Inc.

Global injection pens market share, by application, 2017 (%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global injection pens market on the basis of product, dosage, application, and region:

Injection Pens Product Outlook (Revenue, USD Billion, 2014 – 2025)

  • Disposable

  • Reusable 

Injection Pens Dosage Outlook (Revenue, USD Billion, 2014 – 2025)

  • Fixed

  • Variable

Injection Pens Application Outlook (Revenue, USD Billion, 2014 – 2025)

  • Diabetes

    • Insulin

    • Non-insulin

  • Anaphylaxis

  • Osteoporosis

  • Growth hormone deficiency

  • Arthritis

  • Others

Injection Pens Regional Outlook (Revenue, USD Billion, 2014 – 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Greece

    • Denmark

    • Spain

    • Norway

    • Belgium

    • Austria

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • Australia

    • Singapore

    • Malaysia

    • Sri Lanka

    • Bangladesh

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • UAE

    • Saudi Arabia

    • South Africa

    • Qatar

    • Kuwait

Browse Related Report :

Smart Insulin Pens And Pumps Market :

Digital Diabetes Management Market :

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States